Oct 01, 2017
BioPharm International
This study is an attempt to produce a fusion protein by binding the fragment NT-gp96 in upstream of sequence of the N terminal fragment (NT300) of the NS5B gene in an expression vector.
Oct 01, 2017
BioPharm International
This study outlines methods for an alternative protein-polishing process for challenging proteins.
Oct 01, 2017
BioPharm International
A UHPLC SEC approach for protein aggregate analysis of mAbs is presented.
Oct 01, 2017
BioPharm International
Process analytical testing for biopharmaceuticals requires enhanced methods due to complex bioprocesses.
Oct 01, 2017
BioPharm International
Focusing on whether the product meets its defined quality attributes should help one make reasonable, documentable, and defendable risk-based decisions, according to Susan Schniepp, distinguished fellow at Regulatory Compliance Associates.
Oct 01, 2017
BioPharm International
Mergers and acquisitions are positive for the CDMO industry, but there is a downside.
Oct 01, 2017
BioPharm International
Industry and FDA face new fee structures and new challenges in implementing fee initiatives.
Oct 01, 2017
BioPharm International
There is a lot of interest in delivering biologics via non-invasive routes in attempt to improve patient compliance and convenience.
Oct 01, 2017
BioPharm International
Detecting viral contaminants in biologic-based medicines—and identifying their source—requires a holistic testing approach.
Oct 01, 2017
BioPharm International
Reeling from financial and tropical storms, Puerto Rico needs stable industry to aid its recovery.
native1_300x100
lorem ipsum